• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • NORTH AMERICA EDITION
      Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • NORTH AMERICA EDITION
      North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Biotech Market
    Biotech News
    Biotech Stocks
    • Biotech Market
    • Biotech News
    • Biotech Stocks

    Rennova Health Shares Appeal Win in Eleventh Circuit Court of Appeals

    Bryan Mc Govern
    Sep. 25, 2017 09:02AM PST
    Biotech Investing

    Rennova Health received a favorable decision from the Eleventh Circuit Court of Appeals reversing an earlier decision by the US District Court.

    Rennova Health (NASDAQ:RNVA) received a favorable decision from the Eleventh Circuit Court of Appeals reversing an earlier decision by the US District Court.
    As quoted in the press release:

    Biohealth Medical Laboratory, Inc. and PB Laboratories, LLC (the “Companies”) filed suit against CIGNA Health in 2015 alleging that CIGNA failed to pay claims for laboratory services the Companies provided to patients pursuant to CIGNA-issued and CIGNA-administrated plans. In 2016, the U.S. District Court dismissed part of the Companies’ claims for lack of standing. The Companies appealed that decision to the Eleventh Circuit Court of Appeals, which recently reversed the district court’s decision and found that the Companies have standing to raise claims arising out of traditional insurance plans as well as self-funded plans.
    “This is an exciting development for us,” said Seamus Lagan, Chief Executive Officer, “and allows us to push forward in our pursuit of the total amount of our original claims.”

    Click here to read the full press release.

    Source: www.marketwired.com

    rennova health
    The Conversation (0)

    Go Deeper

    AI Powered

    Intra-Cellular Therapies to Present at the 45th Annual Goldman Sachs Global Healthcare Conference

    A hand holding a double helix.

    Top 5 NASDAQ Genetics Stocks (Updated December 2023)

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Biotech Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×